Annabelle G.
- Country
- France
- Department
- ARAUCO
Research Overview
- Pharmacokinetics and Pharmacodynamics of Reduced-Dose Rivaroxaban in Chronic Hemodialysis Patients Without Oral Anticoagulation Indication
- INduction in Sensitized kidney Transplant recipients without pre-Existing donor-specific AntiboDies: a randomized multicentre trial between a lymphocyte depleting and basiliximab (INSTEAD)
Data & Insights
Has run more than one trial at 1 of 17 partner sites.
Specializations
Nephrology and Renal Care
The investigator specializes in advanced treatments for patients with end-stage renal disease and chronic hemodialysis. Their research encompasses innovative anticoagulation approaches for dialysis patients, focusing on optimizing medication protocols.
- Anticoagulation Management
- Hemodialysis Treatment
- Renal Disease Care
Their work particularly examines the pharmacological aspects of anticoagulation therapy in renal patients.
Transplant Medicine
The investigator focuses on advancing kidney transplantation procedures, with particular emphasis on managing sensitized kidney transplant recipients. Their expertise extends to immunosuppressive therapy optimization and rejection prevention strategies.
- Transplant Immunology
- Rejection Prevention
- Immunosuppressive Protocols
Their research aims to improve post-transplant outcomes through innovative immunological approaches.
Clinical Pharmacology
The investigator studies pharmacokinetics and pharmacodynamics in specialized patient populations. Their research focuses on medication dosing strategies for patients with complex medical conditions.
- Drug Safety Profiles
- Dose Optimization
- Clinical Efficacy Assessment
Their work emphasizes the development of tailored medication regimens for specific patient groups.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.